Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

8.40USD
4:00pm EDT
Change (% chg)

$0.15 (+1.82%)
Prev Close
$8.25
Open
$8.24
Day's High
$8.47
Day's Low
$8.15
Volume
18,185
Avg. Vol
76,416
52-wk High
$23.68
52-wk Low
$5.92

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.38 December 20 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 6.47 8.10 4.70 --
Quarter Ending Dec-18 3 15.21 27.80 7.82 --
Year Ending Dec-18 3 42.27 54.90 35.20 20.95
Year Ending Dec-19 3 24.77 43.80 12.50 68.00
Earnings (per share)
Quarter Ending Sep-18 3 -0.38 -0.12 -0.69 --
Quarter Ending Dec-18 3 -0.07 0.14 -0.20 --
Year Ending Dec-18 3 -1.10 -0.71 -1.32 -2.26
Year Ending Dec-19 3 -1.72 -0.98 -2.20 -2.27

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 8.80 11.67 2.87 32.66
Quarter Ending Mar-18 9.90 10.78 0.88 8.90
Quarter Ending Dec-17 8.88 11.28 2.41 27.12
Quarter Ending Sep-17 3.07 8.78 5.71 186.33
Quarter Ending Jun-17 2.00 0.00 2.00 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6.47 6.47 6.47 7.50 --
Quarter Ending Dec-18 15.21 15.21 15.21 18.21 --
Year Ending Dec-18 42.27 39.20 39.20 40.03 20.95
Year Ending Dec-19 24.77 25.58 25.58 28.10 68.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings